top of page

Key Facts

Million Deaths

1.3

Antimicrobial resistance caused

mortality in 2024

Estimated antimicrobial resistance

caused mortality in 2050

Million Deaths

10

800

Over 10% of global population is

infected with sinusitis every year

Million  Cases

50%

Estimated amount of unnecessary antibiotic prescriptions for sinusitis

Of Prescriptions

11

Annual treatment expenses

for sinusitis in the US alone

Billion USD

Antimicrobial Resistance
Sinusitis

Key Facts

100

Estimated impact of antimicrobial

resistance to global GDP in 2050

Trillion USD

Million Users

2

LATAM

Testilaatikko 2.png

NAM

5

Million Users

Testilaatikko 3.png

Million Users

6

EMEA

APAC

9

Million Users

Market Potential

Million Users

GLOBAL

22

Million Users

APAC

9

Million Users

EMEA

6

Million Users

NAM

5

Million Users

LATAM

2

Flu season. The waiting room is full of patients. A sense of urgency and rush fills the air.

No methods at hand to differentiate between viral and bacterial sinusitis.  Antibiotic treatment is prescribed to be on the safe side. Next patient.

This was the situation also in Finnish primary care in the early 1980s before ultrasound was introduced to help in the diagnosis of sinusitis. Unfortunately, in most parts of the world the situation is still the same. Over 800 million people worldwide suffer from sinusitis every year. Close to half of those affected get an unnecessary antibiotic prescription because the diagnosis is based solely on symptoms. Antibiotic resistance keeps on growing.

Our dedicated team here at Orcason Medical strives to change the situation globally to be as it is in Finland. Fast and reliable diagnosis of sinusitis using the modern Orsinus ultrasound device. Evidence-based antibiotic treatment only for those who truly need it.

Join us in our mission to permanently change the way sinusitis is diagnosed and treated. 

Don't hesitate to contact me at elias.revonta@orcason.com

 It would be my pleasure to tell you more about our vision and future plans.

Elias Revonta

Founder & CEO

Elias investor sivulle.jpg

Join Our Mission

Global Prevalence

According to global studies, 10% of the worlds population is infected with sinusitis every year.

Inadequate Equipment

In most cases sinusitis is diagnosed on the basis of symptoms alone. 

Antibiotic Resistance

Inadequately diagnosed sinusitis causes more unnecessary antibiotic prescriptions than any other disease.

High Costs

Annual sinusitis treatment costs are more than 11 billion USD in the US alone.

Opportunities

Current Problem

  • Most sinusitis diagnoses are done on the basis of symptoms alone

  • Sinusitis is the leading single cause for antibiotic prescriptions

  • 50% of antibiotic prescriptions for sinusitis are unnecessary

  • Unnecessary antibiotic use leads to the rise of antimicrobial resistance

  • Over 30 million doctor visits every year in the US alone

Investor Opportunities

  • Multibillion-dollar annual revenue opportunity as a global solution

  • Recurring revenue stream through probe covers and SaaS-solution

  • Largely unused technology with huge growth potential

  • No direct competitors in the current market

  • Strong possibility to crossover to B2C market via telemedicine

Unique Solution

  • Wireless handheld ultrasound device for the scanning of sinuses

  • Detects the presence or absence of fluid in the sinus cavity

  • Fast, easy and reliable way to simplify sinusitis diagnosis

  • Applicable as standard of care for all suspected sinusitis cases

  • Reduces the amount of unnecessary antibiotic use

Orcason Medical Logo White Official Nettisivu.png

Invest in a disrupting solution that will improve patient outcomes, cut down unnecessary antibiotic prescriptions and significantly reduce healthcare costs

Together we can make a difference and save the power of antibiotics for future generations

bottom of page